Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Diabetes Care

• Publication date

  2003-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/DIACARE.26.12.3264PMID 14633812
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet responsiveness to aspirin in patients with hyperlipidaemia

  2003cited by this paper
• Research pointers: Platelet responsiveness to aspirin in patients with hyperlipidaemia.

  2003cited by this paper
• Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task Force

  2002cited by this paper
• Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.

  2002cited by this paper
• MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Clinical practice. Aspirin for primary prevention of coronary events.

  2002cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• Aspirin for the primary prevention of cardiovascular events: recommendations and rationale.

  2002cited by this paper
• A SPIRIN FOR P RIMARY P REVENTION OF C ORONARY E VENTS

  2002cited by this paper
• Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.

  2002cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• The way I see it: House officers need formal career development

  2002cited by this paper
• Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A2?

  2002cited by this paper
• Aspirin for the Primary Prevention of Cardiovascular Events: Recommendation and Rationale

  2002cited by this paper
• Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project.

  2001cited by this paper
• Primäre Prävention kardiovaskulärer Ereignisse durch ASS und Vitamin E PPP das “Primary Prevention Project”

  2001cited by this paper
• Coronary heart disease in patients with diabetes.

  2000cited by this paper
• Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collab

  2000cited by this paper
• Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trial

  2000influential reference
• Vitamin E supplementation and cardiovascular events in high-risk patients.

  2000cited by this paper
• Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.

  1998cited by this paper
• Elevated Concentrations of Soluble E-Selectin and Vascular Cell Adhesion Molecule-1 in NIDDM: Effect of intensive insulin treatment

  1998cited by this paper
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

  1998cited by this paper
• Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk

  1998cited by this paper
• Total Radical-Trapping Antioxidant Parameter in NIDDM Patients

  1997cited by this paper
• Circulating Vascular Cell Adhesion Molecule-1 (VCAM-1) in Atherosclerotic NIDDM Patients

  1997cited by this paper
• Aspirin Therapy in Diabetes

  1997cited by this paper
• Oxidative Stress and Diabetic Vascular Complications

  1996cited by this paper
• Prevention of vascular events in diabetes mellitus: which “antithrombotic” therapy?

  1996cited by this paper
• Pathogenesis of the Atherosclerotic Lesion: Implications for diabetes mellitus

  1992cited by this paper
• Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators.

  1992cited by this paper
• Final report on the aspirin component of the ongoing Physicians' Health Study.

  1989cited by this paper
• Randomised trial of prophylactic daily aspirin in British male doctors

  1988cited by this paper
• Trial of repeated low-dose aspirin in diabetic angiopathy.

  1986cited by this paper

• Association of cardiovascular risk factors with diabetic kidney disease severity in the Iranian population

  2026cites this paper
• A Thorough Literature Review of the Potential Benefits and Drawbacks of Long-Term Aspirin Use for the Primary Prevention of Cardiovascular Disease.

  2024cites this paper
• Aspirin in Primary Prevention: Looking for Those Who Enjoy It

  2024influential citation
• Effects of Low and High Doses of Aspirin on Inflammatory Markers in Diabesity Patients: A Quasi-Experimental Study

  2024cites this paper
• Association between dietary antioxidants intake and the risk of type 2 diabetes mellitus in a prospective cohort study: Tehran Lipid and Glucose Study

  2023cites this paper
• Lysosomal dysfunction in diabetic cardiomyopathy

  2023cites this paper
• Patients with metabolic dysfunction–associated steatotic liver disease have preserved in vitro responses to antiplatelet drugs

  2023cites this paper
• Acetylsalicylic Acid (aspirin) for Primary Prevention of Cardiovascular Events in Patients with Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

  2023cites this paper
• Aspirin for Primary Prevention of Cardiovascular Diseases: “WALTZ” with the Evidence

  2022cites this paper
• Cardiodiabetology: Newer Pharmacologic Strategies for Reducing Cardiovascular Disease Risks.

  2022cites this paper
• Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

  2022cites this paper
• Aspirin for Primary Stroke Prevention; Evidence for a Differential Effect in Men and Women

  2022cites this paper
• Aspirin mediates protection from diabetic kidney disease by inducing ferroptosis inhibition

  2022cites this paper
• Evaluation of prophylaxis in primary prevention with acetylsalicylic acid in people with diabetes: A scoping review.

  2022cites this paper
• Meta-Analysis of Aspirin for Primary Prevention of Stroke

  2022cites this paper
• Prevención primaria cardiovascular con ácido acetilsalicílico en diabéticos: ¿en qué quedamos?

  2022cites this paper
• Protocol for Testing the Potential Antioxidant Effects of Curcuminoids on Patients with Type 2 Diabetes Mellitus.

  2022cites this paper
• Low-doses aspirin in the primary prevention of cardiovascular disease in patients with diabetes: Meta-analysis stratified by baseline cardiovascular risk.

  2022cites this paper
• Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

  2022cites this paper
• Trends and Determinants of Self-reported Aspirin Use Among Patients With Diabetes Stratified by Presence and Risk of Cardiovascular Diseases: A Repeated Pan-Canadian Cross-sectional Study.

  2021cites this paper
• Stress hyperglycemia may have higher risk of stroke recurrence than previously diagnosed diabetes mellitus

  2021cites this paper
• The Association between Glycosylated Hemoglobin Level and Platelets Reactivity in Patients with Diabetes Mellitus Undergoing Elective Coronary Artery Bypass Grafting

  2021cites this paper
• Benefits and Risks Associated With Aspirin Use in Patients With Diabetes for the Primary Prevention of Cardiovascular Events and Mortality: A Meta-Analysis

  2021cites this paper
• Contemporary Clinical Use of Aspirin: Mechanisms of Action, Current Concepts, Unresolved Questions, and Future Perspectives

  2021cites this paper
• Cardiovascular risk management in type 2 diabetes mellitus: A joint position paper of the Italian Cardiology (SIC) and Italian Diabetes (SID) Societies.

  2021cites this paper
• Stellenwert der ASS-Therapie in der kardio- und zerebrovaskulären Prävention

  2021cites this paper
• Primary prevention of Cardiovascular Diseases among the Middle aged and the Elderly

  2021cites this paper
• Cardiodiabetology: Reducing Risks to Optimize Cardiovascular Disease Outcomes

  2020cites this paper
• Clinical Post-operative Bleeding During Minor Oral Surgical Procedure and In Vitro Platelet Aggregation in Patients on Aspirin Therapy: Are they Coherent?

  2020cites this paper
• Aspirin in Primary Prevention: What Changed? A Critical Appraisal of Current Evidence.

  2020cites this paper
• Features of postoperative therapy in patients with type ІІ diabetes

  2020cites this paper
• Aspirin for primary prevention of atherosclerotic cardiovascular events

  2020cites this paper
• Aspirin for primary prevention of cardiovascular outcomes in diabetes mellitus: An updated systematic review and meta-analysis

  2020cites this paper
• Correlation study between gastronomy culture and content of selenium towards prevalence of cardiovascular and diabetes in West Java, Indonesia.

  2020cites this paper
• Association between High On-Aspirin Platelet Reactivity and Reduced Superoxide Dismutase Activity in Patients Affected by Type 2 Diabetes Mellitus or Primary Hypercholesterolemia

  2020cites this paper
• Aspirin for Primary Atherosclerotic Cardiovascular Disease Prevention as Baseline Risk Increases: A Meta-Regression Analysis.

  2020cites this paper
• All-cause mortality following low-dose aspirin treatment for patients with high cardiovascular risk in remote Australian Aboriginal communities: an observational study

  2020cites this paper
• Antiplatelet strategy in primary and secondary prevention of cardiovascular disease in patients with type 2 diabetes mellitus: A perspective from the guideline appraisal

  2020cites this paper
• Antiplatelet therapies in diabetes

  2020cites this paper
• Diabetes and Vascular Disease: is it all about Glycemia?

  2019cites this paper
• Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials

  2019cites this paper
• Aspirin in the primary prevention of cardiovascular disease on diabetic patients: Systematic review and meta-analysis.

  2019cites this paper
• Aspirin in primary prevention: the triumph of clinical judgement over complex equations

  2019cites this paper
• Primary Prevention of Cardiovascular Events with Aspirin: Toward More Harm than Benefit—A Systematic Review and Meta-Analysis

  2019influential citation
• Hyperglycemia-induced cardiomyocyte death is mediated by lysosomal membrane injury and aberrant expression of cathepsin D.

  2019cites this paper
• The Role of Platelets in Diabetes Mellitus

  2019cites this paper
• Clinical Cardiovascular Disease Trials: The Vitamin E Case

  2019cites this paper
• Low-Dose Aspirin for the Primary Prevention of Cardiovascular Disease in Diabetic Individuals: A Meta-Analysis of Randomized Control Trials and Trial Sequential Analysis

  2019cites this paper
• Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets

  2018cites this paper
• Untargeted Metabolic Profiling Cell-Based Approach of Pulmonary Artery Smooth Muscle Cells in Response to High Glucose and the Effect of the Antioxidant Vitamins D and E

  2018cites this paper
• [Selection of antiplatelet therapy for patients with stable angina].

  2018cites this paper
• Haptoglobin and haptoglobin genotypes in diabetes: A silver bullet to identify the responders to antioxidant therapy?

  2018cites this paper
• Event simulation and external validation applied in published health economic models for obesity: a systematic review

  2018cites this paper
• Edinburgh Research Explorer The prevention of progression of arterial disease and diabetes (POPADAD) trial

  2018cites this paper
• Aspirin and diabetes mellitus in primary prevention: the Endless Conundrum.

  2018influential citation
• Heart-breaking aspirin interruption.

  2017cites this paper
• Aspirin Use Among Adults With Diabetes

  2017cites this paper
• Volume-sensitive outwardly rectifying chloride channel blockers protect against high glucose-induced apoptosis of cardiomyocytes via autophagy activation

  2017cites this paper
• Platelets, diabetes and myocardial ischemia/reperfusion injury

  2017cites this paper
• Sex Differences in Type-2 Diabetes: Implications for Cardiovascular Risk Management.

  2017cites this paper
• An Investigation into Gilbert’s Syndrome: Understanding the Role of Unconjugated Bilirubin in Targeting Platelet and Haemostatic Mechanisms Associated with Thrombotic Risk Factors

  2017cites this paper
• Interventions in type 2 diabetes mellitus and cardiovascular mortality-An overview of clinical trials.

  2017cites this paper
• Aspirin for Primary Prevention.

  2017cites this paper
• Interaction Between the Haptoglobin Genotype and Vitamin E on Cardiovascular Disease in Diabetes

  2017cites this paper
• Aspirin for primary prevention of cardiovascular and all‐cause mortality events in diabetes: updated meta‐analysis of randomized controlled trials

  2017cites this paper
• Total Antioxidant Capacity from Dietary Supplement Decreases the Likelihood of Having Metabolic Syndrome in Korean Adults

  2017cites this paper
• 15 Diabetic Nephropathy : A Cardiovascular Risk Factor

  2017cites this paper
• Are diabetes guidelines truly evidence based?

  2017cites this paper
• Short-term efficacy and safety of three different antiplatelet regimens in diabetic patients treated with primary percutaneous coronary intervention: a randomised study.

  2017cites this paper
• Growth curves in Down syndrome with congenital heart disease.

  2016cites this paper
• Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial

  2016cites this paper
• Mitochondrial quality control in the diabetic heart.

  2016cites this paper
• The Benefit and Safety of Aspirin for Primary Prevention of Ischemic Stroke: A Meta-Analysis of Randomized Trials

  2016cites this paper
• Causes and consequeces of delay in vascular surgery

  2016cites this paper
• The Protective Effect of Antioxidants Consumption on Diabetes and Vascular Complications

  2016cites this paper
• Anti-inflammatory diet and 10-year (2002-2012) cardiovascular disease incidence: The ATTICA study.

  2016cites this paper
• Aspirin for primary prevention of cardiovascular disease in patients with diabetes: A meta-analysis.

  2016influential citation
• Compliance with USPSTF recommendations on aspirin for prevention of cardiovascular disease in men

  2016cites this paper
• Clinical implications of oxidative stress and potential role of natural antioxidants in diabetic vascular complications.

  2016cites this paper
• Aspirin dosing frequency in the primary and secondary prevention of cardiovascular events

  2016cites this paper
• Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force

  2016cites this paper
• FREQUENCY OF ASPIRIN RESISTANCE IN PATIENTS WITH TYPE 1 AND 2 DIABETES MELLITUS AND ITS ASSOCIATION WITH METABOLIC PARAMETERS

  2016cites this paper
• Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.

  2015cites this paper
• Glycated albumin predicts the effect of dual and single antiplatelet therapy on recurrent stroke

  2015cites this paper
• Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association

  2015cites this paper
• Screening for Abnormal Glucose and Type 2 Diabetes Mellitus: A Systematic Review to Update the 2008 U.S. Preventive Services Task Force Recommendation

  2015cites this paper
• AHA/ADA Scientific Statement

  2015cites this paper
• Aspirin in diabetes mellitus: mechanisms and clinical implications

  2015cites this paper
• High-risk type-2 diabetes mellitus patients, without prior ischemic events, have normal blood platelet functionality profiles: a cross-sectional study

  2015cites this paper
• Diabetes mellitus and the cardiovascular complications

  2015cites this paper
• Optimizing anti-platelet management in the type II diabetic with CAD: Focus on newer therapies

  2015cites this paper
• Evaluation of low-dose aspirin for primary prevention of ischemic stroke among patients with diabetes: a retrospective cohort study

  2015cites this paper
• Which people should take aspirin for primary prevention of cardiovascular disease?

  2015cites this paper
• Hemostatic abnormalities in diabetes mellitus

  2015cites this paper
• Statins and Aspirin: Do They Really Work in Women?

  2015cites this paper
• Suppressive effect of citalopram on plasma concentrations of thromboxane B2

  2015cites this paper
• Autophagy and mitophagy in diabetic cardiomyopathy.

  2015cites this paper
• Diabetes mellitus and heart failure - an overview of epidemiology and management

  2015cites this paper
• Oxidative Stress in Diabetes Mellitus and Possible Interventions

  2014cites this paper
• α-Tocopherol Supplementation, Lipid Profile, and Insulin Sensitivity in Diabetes Mellitus Type 2

  2014cites this paper